Viral vectors are the buzz word in the world of gene and gene-modified cell therapies – but have you ever understood why?
Viral vector technology is fundamental for the successful engineering and delivery of life-saving gene and gene-modified cell therapies, yet mishandling or inappropriate vector selection could sabotage your therapy and compromise patient safety.
Over 5 sessions, this course will not only explore the underlying virology, but familiarize you with the best practices to ensure you are using the most appropriate vector for your product.
You will learn: how vectors are engineered; how gene size and transfection efficiency influence vector selection; as well as, how to contrast purification requirements and techniques between vectors used for gene and gene-modified cell therapies.
Live Online Academies
Gain real-time access to a subject matter expert delivering online training in a structured virtual classroom environment. Live online academies are virtual versions of some of our most popular face-to-face courses, delivered in bitesize sessions of 1.5-3 hours online.
Over 2 weeks students will learn through:
- Live interactive bitesize sessions
- Direct interaction with the trainer during live sessions
- Participation in interactive features within sessions including polls, Q&A, break out rooms, tasks, case studies, and more
- Revisiting recorded sessions with unlimited access for 30 days
- Interaction with peers during live sessions and through the online forum
Timings and dates are subject to change - final confirmation will be provided with login details. Delegates will receive login instructions within a week of the course start date. If you have any questions please contact firstname.lastname@example.org.
What will you learn?
Understand why viruses are used to engineer and deliver gene-modified cell and gene therapies
Familiarize yourself with how viral vectors are engineered, and how this translates into purification techniques
Viral vector selection
Consider important factors for selecting the most appropriate vector for your product, including gene size and transfection efficiency
Understand how purification requirements, such as host cell DNA and residual empty capsids, are influenced by vector manufacture and end-use application, compare how these requirements differ between gene therapy and gene-modified cell therapies
Appreciate that specific purification techniques are influenced by specific purification requirements of your product, then consider the different tests available to assess purification including qPCR, ELISA and TC1D50
Who is this course for?
This course is directly applicable to people working on the manufacturing of gene therapies and gene-modified cellular therapies. Relevant departments will include:
- Gene Therapy Process Development
- Cell Therapy Engineering
- Cell Therapy Process Development
- Quality Control/Assurance
- Regulatory Affairs
- Final Release Testing
Delegates of our live online academies said...
would attend another live online academy
found the course beneficial to their day to day role
would recommend the course to others
25% discount on Routledge books
As a student on the course you will receive a 25% discount on any Routledge books or eBooks. To view the full product range visit the Routledge website www.routledge.com.
Examples of books and eBooks within biopharmaceuticals include:
- Gene and Cell therapies: Market Access and Funding
- Gene and Cell Therapy: Therapeutic Mechanisms and Strategies
- Bioprocess Engineering: Downstream Processing
- Bioreactors: Animal Cell Culture Control for Bioprocess Engineering
- Fundamentals of Modern Bioprocessing
- And more